Fusion Pharmaceuticals, a member of the AstraZeneca Group, is a clinical-stage oncology company focused on developing next generation radioconjugates (RCs) as precision medicines. Fusion has multiple pipeline programs entering early FIH trials. In addition, Fusion is pursuing combination programs between RCs and other therapeutic modalities including DNA Damage Response Inhibitors (DDRis) and immune-oncology agents. To support execution for these programs, Fusion has a fully operational Good Manufacturing Practice (GMP) compliant state-of-the-art radioconjugate manufacturing facility to meet the demand for our growing pipeline of RCs.

Overview

The Microbiology Supervisor is responsible for leading and supervising all aspects of microbiological control in a regulated aseptic manufacturing environment, with a focus on sterile radiopharmaceutical products. This role combines technical microbiology expertise with hands-on supervisory responsibilities, ensuring robust ...